MSD looking at global manufacturing sites to make its Covid pill

Molnupiravir has become one of the most highly anticipated coronavirus medications, as the pill is relatively cheap to make and easy to transport
MSD in Brinny, Co Cork, where 900 people are employed.

MSD in Brinny, Co Cork, where 900 people are employed.

Drugmaker Merck, which is known in Ireland as MSD, which employs 2,800 people in Cork and Carlow and at other major sites – said its closely-watched Covid-19 antiviral pill could bring in as much as $7bn (€6bn) in global sales. 

Its molnupiravir has become one of the most highly anticipated coronavirus medications, as the pill is relatively cheap to make and easy to transport. The drugmaker has taken steps to make sure the drug will be distributed widely, including in low-income countries.

You have reached your article limit. Already a subscriber? Sign in

Save €40 on an Annual Subscription.​

Continue reading within unlimited digital access and exclusive subscriber benefits.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited